Anqi Lin

Area of research

Oncology · Pulmonary and Respiratory Medicine

Research interest

Research focused on Tumor microenvironment and Cancer, with related work in Cancer research, Immunotherapy, Immune system. Notable publications include 'ZFHX3 mutation as a protective biomarker for immune checkpoint blockade in non-small cell lung cancer', 'Potential anti-tumor effects of regulatory T cells in the tumor microenvironment: a review', and 'Characterization of second primary malignancies post CAR T-cell therapy: real-world insights from the two global pharmacovigilance databases of FAERS and VigiBase'.

The microbiome in cancer

iMeta 2025cited by 45position: firstdoi

Heterogeneity of Intratumoral Microbiota Within the Tumor Microenvironment and Relationship to Tumor Development

Med Research 2025cited by 41position: lastdoi

The Future of Cancer Therapy: Nanomaterials and Tumor Microenvironment

iMetaMed 2025cited by 23position: middledoi

T-cell Senescence in the Tumor Microenvironment

Cancer Immunology Research 2025cited by 18position: middledoi

Microbiome meets immunotherapy: unlocking the hidden predictors of immune checkpoint inhibitors

npj Biofilms and Microbiomes 2025cited by 16position: middledoi

NK Cell Senescence in Cancer: From Molecular Mechanisms to Therapeutic Opportunities

Aging and Disease 2025cited by 14position: middledoi

Decoding the hepatic fibrosis-hepatocellular carcinoma axis: from mechanisms to therapeutic opportunities

Hepatology International 2025cited by 8position: firstdoi

Protein Spatial Structure Meets Artificial Intelligence: Revolutionizing Drug Synergy–Antagonism in Precision Medicine

Advanced Science 2025cited by 8position: firstdoi

FigureYa: A Standardized Visualization Framework for Enhancing Biomedical Data Interpretation and Research Efficiency

iMetaMed 2025cited by 6position: middledoi

Unveiling large multimodal models in pulmonary CT: A comparative assessment of generative AI performance in lung cancer diagnostics

View 2025cited by 2position: middledoi

Potential anti-tumor effects of regulatory T cells in the tumor microenvironment: a review

Journal of Translational Medicine 2024cited by 89position: middledoi

Characterization of second primary malignancies post CAR T-cell therapy: real-world insights from the two global pharmacovigilance databases of FAERS and VigiBase

EClinicalMedicine 2024cited by 56position: middledoi

STAGER checklist: Standardized testing and assessment guidelines for evaluating generative artificial intelligence reliability

iMetaOmics. 2024cited by 29position: middledoi

Immune Checkpoints in B Cells: Unlocking New Potentials in Cancer Treatment

Advanced Science 2024cited by 23position: middledoi

Correlation between second and first primary cancer: systematic review and meta-analysis of 9 million cancer patients

British journal of surgery 2023cited by 30position: middledoi

ZFHX3 mutation as a protective biomarker for immune checkpoint blockade in non-small cell lung cancer

Cancer Immunology Immunotherapy 2020cited by 140position: middledoi

Recent publications

Grants

Frequent collaborators